592 related articles for article (PubMed ID: 19165707)
1. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Wilken B; Aslami B; Backes H
Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
[TBL] [Abstract][Full Text] [Related]
2. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
Khan A; Pawar G
W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
[TBL] [Abstract][Full Text] [Related]
3. Successful management of drooling with botulinum toxin A in neurologically disabled children.
Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
[TBL] [Abstract][Full Text] [Related]
4. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
Alrefai AH; Aburahma SK; Khader YS
Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin injections for children with excessive drooling.
Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
[TBL] [Abstract][Full Text] [Related]
6. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
Basciani M; Di Rienzo F; Fontana A; Copetti M; Pellegrini F; Intiso D
Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
Reid SM; Johnstone BR; Westbury C; Rawicki B; Reddihough DS
Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
[TBL] [Abstract][Full Text] [Related]
9. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?
Nordgarden H; Østerhus I; Møystad A; Asten P; Johnsen UL; Storhaug K; Loven JØ
J Child Neurol; 2012 Apr; 27(4):458-64. PubMed ID: 21940695
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence.
Schroeder AS; Kling T; Huss K; Borggraefe I; Koerte IK; Blaschek A; Jahn K; Heinen F; Berweck S
Neuropediatrics; 2012 Feb; 43(1):27-36. PubMed ID: 22430158
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
[TBL] [Abstract][Full Text] [Related]
12. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures.
Erasmus CE; van Hulst K; Scheffer AR; van Limbeek J; van den Hoogen FJ; Rotteveel JJ; Jongerius PH
Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-guided botulinum toxin injections for treatment of drooling.
Breheret R; Bizon A; Jeufroy C; Laccourreye L
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):224-9. PubMed ID: 21600865
[TBL] [Abstract][Full Text] [Related]
14. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands.
Turk-Gonzales M; Odderson IR
Neurorehabil Neural Repair; 2005 Mar; 19(1):58-61. PubMed ID: 15673844
[TBL] [Abstract][Full Text] [Related]
15. US-guided botulinum toxin injection for excessive drooling in children.
Çiftçi T; Akıncı D; Yurttutan N; Akhan O
Diagn Interv Radiol; 2013; 19(1):56-60. PubMed ID: 22798155
[TBL] [Abstract][Full Text] [Related]
16. Does motor performance matter in botulinum toxin efficacy for drooling?
Erasmus CE; Scheffer AR; van Hulst K; van Limbeek J; van den Hoogen FJ; Rotteveel JJ; Jongerius PH
Pediatr Neurol; 2011 Aug; 45(2):95-9. PubMed ID: 21763949
[TBL] [Abstract][Full Text] [Related]
17. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
18. Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea.
Sidebottom AJ; May JE; Madahar AK
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):113-6. PubMed ID: 22658501
[TBL] [Abstract][Full Text] [Related]
19. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
20. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
